We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+30.52%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$54.4B
AUM Growth
+$18.8B
Cap. Flow
+$10.1B
Cap. Flow %
18.55%
Top 10 Hldgs %
19.63%
Holding
2,529
New
693
Increased
913
Reduced
559
Closed
265

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$719M
2
AMZN icon
Amazon
AMZN
+$692M
3
PG icon
Procter & Gamble
PG
+$393M
4
AMD icon
Advanced Micro Devices
AMD
+$330M
5
B
Barrick Mining
B
+$313M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$935M
2
ABBV icon
AbbVie
ABBV
+$504M
3
MS icon
Morgan Stanley
MS
+$407M
4
INTC icon
Intel
INTC
+$349M
5
C icon
Citigroup
C
+$274M

Sector Composition

Rank Sector Weight
1 Technology 25.33%
2 Consumer Discretionary 16.11%
3 Healthcare 10.91%
4 Financials 10.87%
5 Materials 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESSC
2201
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$142K ﹤0.01%
+14,400
New +$140K
GBL
2202
DELISTED
GAMCO Investors, Inc.
GBL
$140K ﹤0.01%
10,540
CYCN icon
2203
Cyclerion Therapeutics
CYCN
$16.7M
$138K ﹤0.01%
+1,171
New +$97.9K
PLX icon
2204
Protalix BioTherapeutics
PLX
$196M
$131K ﹤0.01%
+34,653
New +$118K
UBX
2205
DELISTED
Unity Biotechnology
UBX
$127K ﹤0.01%
+1,460
New +$108K
REFR icon
2206
Research Frontiers
REFR
$17.2M
$123K ﹤0.01%
+30,400
New +$113K
KIN
2207
DELISTED
Kindred Biosciences, Inc.
KIN
$123K ﹤0.01%
+27,300
New +$122K
VIOT
2208
Viomi Technology
VIOT
$49.6M
$122K ﹤0.01%
+23,100
New +$127K
PAYA
2209
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$122K ﹤0.01%
+10,900
New +$113K
ATTO
2210
DELISTED
Atento S.A.
ATTO
$121K ﹤0.01%
20,465
-4,716
-19% -$24.8K
GORO icon
2211
Goldgroup Mining Inc.
GORO
$184M
$120K ﹤0.01%
+29,100
New +$112K
TIPT icon
2212
Tiptree Inc
TIPT
$671M
$115K ﹤0.01%
17,845
BELFB
2213
Bel Fuse Inc Class B
BELFB
$4.19B
$114K ﹤0.01%
10,603
MCHX icon
2214
Marchex
MCHX
$77.1M
$114K ﹤0.01%
72,080
-43,818
-38% -$66.3K
ABUS icon
2215
Arbutus Biopharma
ABUS
$923M
$113K ﹤0.01%
+62,321
New +$102K
CHAP
2216
DELISTED
Chaparral Energy, Inc.
CHAP
$113K ﹤0.01%
+174,800
New +$92K
XERS icon
2217
Xeris Biopharma Holdings
XERS
$1.53B
$112K ﹤0.01%
+42,000
New +$146K
ORTX
2218
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$111K ﹤0.01%
+1,850
New +$169K
RDI icon
2219
Reading International Class A
RDI
$33.2M
$109K ﹤0.01%
25,654
SBT
2220
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$105K ﹤0.01%
29,431
-16,900
-36% -$55.6K
GNW icon
2221
Genworth Financial
GNW
$3.7B
$104K ﹤0.01%
+45,200
New +$142K
ASX icon
2222
ASE Group
ASX
$85B
$101K ﹤0.01%
+22,200
New +$94.7K
GSAT icon
2223
Globalstar
GSAT
$10.8B
$101K ﹤0.01%
+20,620
New +$97.9K
DNTH icon
2224
Dianthus Therapeutics
DNTH
$6.07B
$98K ﹤0.01%
+819
New +$115K
STRO icon
2225
Sutro Biopharma
STRO
$415M
$97K ﹤0.01%
+1,244
New +$119K

Similar funds

Arrowstreet Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Arrowstreet Capital held 2,529 positions worth $54.4B, up 53% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arrowstreet Capital deployed $10.1B of net new capital in Q2 2020, opening 693 new positions and adding to 913 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 6,333,500 shares worth $182M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $935M trimmed.

  • Arrowstreet Capital's largest Q2 2020 buy was iShares MSCI Brazil ETF: 6,333,500 shares worth $182M.
  • Arrowstreet Capital added most to Alibaba in Q2 2020, an estimated $719M increase.
  • Arrowstreet Capital's biggest Q2 2020 reduction was Apple, cutting an estimated $935M.
  • Arrowstreet Capital fully exited Raytheon Company in Q2 2020, selling an estimated $100M.
  • Arrowstreet Capital's ten largest holdings make up 20% of its $54.4B portfolio in Q2 2020.
  • Arrowstreet Capital opened 693 new positions and closed 265 in Q2 2020.
  • Arrowstreet Capital's portfolio value rose 53% quarter-over-quarter to $54.4B.

Based on Arrowstreet Capital's 13F filing for Q2 2020, filed 12 Aug 2020.